Fluorescent peptide-based sensors for the ratiometric detection of nanomolar concentration of heparin in aqueous solutions and in serum.

Anal Chim Acta

Bioorganic Chemistry Laboratory, Center for Design and Applications of Molecular Catalysts, Department of Chemistry and Chemical Engineering, Inha University, 253 Yonghyun-Dong, Nam-Gu, Incheon, 402-751, Korea. Electronic address:

Published: May 2015

New fluorescent peptide-based sensors (1-3) for monitoring heparin in serum sample were synthesized using short peptides (1∼3mer) as a receptor. The peptide-based sensors (2 and 3) showed a sensitive ratiometric response to heparin both in aqueous buffered solution (10 mM HEPES, pH 7.4) and in 2% human serum sample by increase of excimer emission of pyrene at 480 nm and concomitant decrease of monomer emission of pyrene at 376 nm, whereas the peptide-based sensor 1 showed a turn off response only by decrease of monomer emission at 376 nm. 2 and 3 exhibited excellent selectivity toward heparin among various anions and competitors of heparin including chondroitin 4-sulfate (ChS) and hyaluronic acid (HA). Peptide-based sensor 3 showed a more sensitive response to heparin than 2. The detection limit of 3 was determined as 36 pM (R(2) = 0.998) for heparin in aqueous solution and 204 pM (R(2) = 0.999) for heparin in aqueous solutions containing 2% human serum. The peptide-based sensors, 2 and 3 provided a practical and potential tool for the detection and quantification of heparin in real biological samples.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aca.2015.03.001DOI Listing

Publication Analysis

Top Keywords

peptide-based sensors
16
heparin aqueous
16
heparin
9
fluorescent peptide-based
8
aqueous solutions
8
serum sample
8
response heparin
8
human serum
8
emission pyrene
8
decrease monomer
8

Similar Publications

Impedimetric Sensor for SARS-CoV-2 Spike Protein Detection: Performance Assessment with an ACE2 Peptide-Mimic/Graphite Interface.

Biosensors (Basel)

December 2024

Escuela de Biotecnología, Facultad de Ciencias, Ingeniería y Tecnología, Universidad Mayor, Camino La Pirámide 5750, Huechuraba, Santiago 8580745, Chile.

The COVID-19 pandemic has prompted the need for the development of new biosensors for SARS-CoV-2 detection. Particularly, systems with qualities such as sensitivity, fast detection, appropriate to large-scale analysis, and applicable in situ, avoiding using specific materials or personnel to undergo the test, are highly desirable. In this regard, developing an electrochemical biosensor based on peptides derived from the angiotensin-converting enzyme receptor 2 (ACE2) is a possible answer.

View Article and Find Full Text PDF

Copper, along with gold, was among the first metals that humans employed. Thus, the copper pollution of the world's water resources is escalating, posing a significant threat to human health and aquatic ecosystems. It is crucial to develop detection technology that is both low-cost and feasible, as well as ultra-selective and sensitive.

View Article and Find Full Text PDF

Innovative Peptide-Based Plasmonic Optical Biosensor for the Determination of Cholesterol.

Biosensors (Basel)

November 2024

Biochemistry and Molecular Biology Unit, Department of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Campus "Aurelio Saliceti" Via Renato Balzarini n. 1, 64100 Teramo, Italy.

Article Synopsis
  • Plasmonic biosensors are gaining popularity in scientific and medical fields due to their ability to detect biomolecular and chemical interactions with high sensitivity and precision.
  • One of the ongoing challenges is accurately detecting low molecular weight substances, like free cholesterol, which is crucial for diagnostic tools but difficult due to its size and properties.
  • The study introduces a new approach using a cholesterol-binding peptide along with plasmonic optical readout that achieves a very low detection limit and operates effectively in a specific concentration range, potentially enhancing cholesterol measurement methods.
View Article and Find Full Text PDF

Mercury, a toxic heavy metal produced through both natural and anthropogenic processes, is found in all of Earth's major systems. Mercury's bioaccumulation characteristics in the human body have a significant impact on the liver, kidneys, brain, and muscles. In order to detect Hg ions, a highly sensitive and specific fluorescent biosensor has been developed using a novel, modified seven amino acid peptide, FY7.

View Article and Find Full Text PDF

Background: The EF-hand Ca sensor protein S100A1 has been identified as a molecular regulator and enhancer of cardiac performance. The ability of S100A1 to recognize and modulate the activity of targets such as SERCA2a (sarcoplasmic reticulum Ca ATPase) and RyR2 (ryanodine receptor 2) in cardiomyocytes has mostly been ascribed to its hydrophobic C-terminal α-helix (residues 75-94). We hypothesized that a synthetic peptide consisting of residues 75 through 94 of S100A1 and an N-terminal solubilization tag (S100A1ct) could mimic the performance-enhancing effects of S100A1 and may be suitable as a peptide therapeutic to improve the function of diseased hearts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!